The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...

Androgenic alopecia, commonly known as male or female pattern baldness, affects millions worldwide, offering few treatment ...

The FDA has granted accelerated approval to Datroway for adults with previously-treated, locally advanced or metastatic EGFR-mutated NSCLC.

Wondering about minoxidil 10% or higher for hair loss? When it comes to this topical product, a higher strength doesn’t ...

Meet the experts: Chesahna Kindred, MD, is a dermatologist in Marriottsville, Maryland, who specializes in hair loss. Melissa Piliang, MD, is a dermatologist and hair loss specialist at the Cleveland ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

Matthew Riccardi was just 11 years old when he was diagnosed with the same condition: alopecia areata, an autoimmune disorder ...

Dato-DXd was granted accelerated approval for use in adults with EGFR-mutated NSCLC after EGFR-targeted therapy and platinum-based chemotherapy.

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks.

ALEXANDRIA, VA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- ● The NPF Seal of Recognition highlights products that prove a commitment to being safe and non-irritating for people with psoriasis ...

The FDA has approved Sun Pharma’s Leqselvi (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata. The novel, oral Janus kinase (JAK) inhibitor targets the JAK1 and JAK2 ...